Fortas, Feriel
Di Nardo, Matteo
Yousef, Nadya
Humbert, Marc
De Luca, Daniele http://orcid.org/0000-0002-3846-4834
Article History
Received: 9 February 2021
Revised: 19 May 2021
Accepted: 31 May 2021
First Online: 6 June 2021
Declarations
:
: N/A
: N/A
: N/A
: Prof. Humbert reports personal fees from Acceleron, grants and personal fees from Actelion, grants and personal fees from Bayer, personal fees from GSK, personal fees from Merck, personal fees from Novartis, personal fees from Astrazeneca, personal fees from Sanofi, outside the submitted work The other authors have no conflict of interest or competing interest to declare.
Free to read: This content has been made available to all.